These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35491726)

  • 1. Evaluation of the safety of 500 mg intravenous push thiamine at a tertiary academic medical center.
    Aldhaeefi M; McLaughlin K; Goodberlet M; Szumita P
    Sci Prog; 2022; 105(2):368504221096539. PubMed ID: 35491726
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of intravenous push thiamine administration at a tertiary academic medical center.
    McLaughlin K; Joyal K; Lee S; Corrado M; Marquis K; Anger K; Szumita P
    J Am Pharm Assoc (2003); 2020; 60(4):598-601. PubMed ID: 31932197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Safety of Intravenous Thiamine Administration in a Large Academic Medical Center.
    Tjugum SL; Hedrick TL; Jean SJ; Heeney SA; Rohde KA; Campbell-Bright SL
    J Pharm Pract; 2021 Jun; 34(3):397-402. PubMed ID: 31495250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaphylactic shock and cardiac arrest caused by thiamine infusion.
    Juel J; Pareek M; Langfrits CS; Jensen SE
    BMJ Case Rep; 2013 Jul; 2013():. PubMed ID: 23853017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Adverse Reactions to Parenteral Thiamine in the Treatment of Wernicke's Encephalopathy, and Recommendations.
    Thomson A; Guerrini I; Marshall EJ
    Alcohol Alcohol; 2019 Dec; 54(6):609-614. PubMed ID: 31565743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A CASE OF ANAPHYLAXIS INDUCED BY VITAMIN B1 DERIVATIVE IN VITAMIN B INFUSION FORMULATION FOR INTRAVENOUS INJECTION].
    Kumagai J; Adachi A; Nagahama M; Yamada H; Masuda Y; Kitamura H
    Arerugi; 2023; 72(5):479-484. PubMed ID: 37460290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of Intravenous Olanzapine Administration at a Tertiary Academic Medical Center.
    Hunt NF; McLaughlin KC; Kovacevic MP; Lupi KE; Dube KM
    Ann Pharmacother; 2021 Sep; 55(9):1127-1133. PubMed ID: 33455436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of Intravenous Push Levetiracetam Compared to Intravenous Piggyback at a Tertiary Academic Medical Center: A Retrospective Analysis.
    Alkazemi A; McLaughlin KC; Chan MG; Schontz MJ; Anger KE; Szumita PM
    Drug Saf; 2022 Jan; 45(1):19-26. PubMed ID: 34716562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaphylaxis from administration of intravenous thiamine.
    Stephen JM; Grant R; Yeh CS
    Am J Emerg Med; 1992 Jan; 10(1):61-3. PubMed ID: 1736919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylaxis to parenteral thiamine (vitamin B1).
    Morinville V; Jeannet-Peter N; Hauser C
    Schweiz Med Wochenschr; 1998 Oct; 128(44):1743-4. PubMed ID: 9846348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Intravenous Push Valproate Compared with Intravenous Piggyback at a Tertiary Academic Medical Center.
    Wang FY; McLaughlin KC; Schontz MJ; DeGrado JR; Dannemiller RE
    Clin Drug Investig; 2024 Mar; 44(3):175-181. PubMed ID: 38363545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-hospital treatment of bee and wasp induced anaphylactic reactions: a retrospective study.
    Ruiz Oropeza A; Mikkelsen S; Bindslev-Jensen C; Mortz CG
    Scand J Trauma Resusc Emerg Med; 2017 Jan; 25(1):4. PubMed ID: 28088250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of Intravenous Push Ertapenem Compared to Intravenous Piggyback at a Tertiary Academic Medical Center.
    Corrado MJ; Riselli A; McLaughlin KC; Szumita PM; Anger KE
    J Pharm Pract; 2023 Apr; 36(2):281-285. PubMed ID: 34384303
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathogenesis of anaphylactic reactions following thiamine administration].
    Blum KU; Kasemir H; Scharfe W
    Verh Dtsch Ges Inn Med; 1974; 80():1369-71. PubMed ID: 4454425
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anaphylactic reaction caused by vitamin B1].
    Villas Martínez F; Joral A; Garmendia Goitia JF
    Med Clin (Barc); 1993 Feb; 100(8):316. PubMed ID: 8464276
    [No Abstract]   [Full Text] [Related]  

  • 16. A toxicity study of parenteral thiamine hydrochloride.
    Wrenn KD; Murphy F; Slovis CM
    Ann Emerg Med; 1989 Aug; 18(8):867-70. PubMed ID: 2757284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency Treatment of Anaphylactic Reactions in Air Rescue Missions: An Eight-Year Analysis of a German Rescue Helicopter Base.
    Lakner T; Cuevas M; Polk ML; Petrowski K; Frank M
    Prehosp Disaster Med; 2021 Oct; 36(5):586-592. PubMed ID: 34425933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of Intravenous Push Lacosamide Compared With Intravenous Piggyback at a Tertiary Academic Medical Center.
    McLaughlin K; Carabetta S; Hunt N; Schuler BR; Ting C; Tran LK; Szumita PM; Anger KE
    Ann Pharmacother; 2021 Feb; 55(2):181-186. PubMed ID: 32686466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylactic shock following intramuscular thiamine chloride.
    TETREAULT AF; BECK IA
    Ann Intern Med; 1956 Jul; 45(1):134-8. PubMed ID: 13340575
    [No Abstract]   [Full Text] [Related]  

  • 20. Anaphylactic shock following intravenous administration of thiamine chloride; report of a case.
    ARMANINO LP; SCOTT WS
    Calif Med; 1950 Mar; 72(3):178. PubMed ID: 15405032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.